default author photo

Leonidas Stamatatos

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division

Seattle, WA 98109-1024

United States

SCHOLARLY PAPERS

3

DOWNLOADS

166

TOTAL CITATIONS

8

Scholarly Papers (3)

1.

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy

Number of pages: 32 Posted: 18 May 2021
Fred Hutchinson Cancer Research Center - Division of Public Health Sciences, Vanderbilt University - Department of Pharmacology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Global Health, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Clinical Research Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 86 (771,553)
Citation 2

Abstract:

Loading...

Mutants, Mutations, SARS-CoV-2, Spike protein, Statistical Learning, Variants, Viral Residue Variants

2.

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

Number of pages: 55 Posted: 01 Apr 2021
Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Department of Pediatrics, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, University of Washington - Division of Allergy and Infectious Diseases, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Pediatrics, Centre de Recherche du CHUM, Emory University - Center for Childhood Infections and Vaccines, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 48 (1,097,529)
Citation 4

Abstract:

Loading...

SARS-CoV-2, SARS-CoV-1, S2 subunit, RBD, NTD, neutralization, monoclonal antibodies, B.1.351

3.

Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy

Number of pages: 85 Posted: 01 Apr 2021
Yale University - Section of Infectious Diseases, Centre de Recherche du CHUM, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Yale University - Department of Microbial Pathogenesis, McGill University - Department of Microbiology and Immunology, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Western Ontario, Uniformed Services University of the Health Sciences - Infectious Disease Division, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Regensburg - Department of Nephrology, Yale University - Section of Infectious Diseases, Yale University - Department of Immunobiology, The University of Western Ontario - Molecular Medicine Research Laboratories, University of Western Ontario - Department of Microbiology and Immunology, University of Vermont - Division of Immunobiology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Centre de Recherche du CHUM, - Division of Vaccine Research, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Centre de Recherche du CHUM, Yale University - Section of Infectious Diseases and Yale University - Department of Microbial Pathogenesis
Downloads 32 (1,290,922)
Citation 2

Abstract:

Loading...

SARS-CoV-2, COVID-19, nanoluciferase, bioluminescence imaging, neutralizing antibodies, convalescent patients, human ACE2 transgenic mice, monocytes, natural killer cells, monocytes, pathogenesis, inflammatory cytokines, Fc effector functions